Cesar Adolfo Sommer

6 Patents

• US125772832026

  Knockdown or Knockout of One or More of TAP2, NLRC5, B2m, TRAC, RFX5, RFXAP and RFXANK to Mitigate T Cell Recognition of Allogeneic Cell Products

  Allogene Therapeutics, Inc.

  0 cites
• US125772902026

  Fasl Expression and Fasr Gene Knockout to Protect Therapeutic Cells from Allogeneic Rejection and Activation-induced Cell Death

  Allogene Therapeutics, Inc.

  0 cites
• US122960122025

  Chimeric Antigen Receptors Targeting FLT3

  PFIZER Inc.

  0 cites
• US122029102025

  Antibodies Specific for FLT3 and Their Uses

  PFIZER Inc.

  0 cites
• US120362432024

  BCMA CAR-T Cells with Enhanced Activities

  Allogene Therapeutics, Inc.

  0 cites
• US119127762024

  Chimeric Antigen Receptors Targeting B-cell Maturation Antigen

  PFIZER Inc.

  0 cites